The predominant gene mutations in NSCLC include EGFR mutations, ALK fusions, and KRAS mutations, while less prevalent mutations include MET amplification, ROS1 fusions, NTRK translocations, and RET mutations[4]. Here, EGFR is linked to non-small cell lung carcinoma.